Phosphoproteomic analysis of neoadjuvant breast cancer suggests that increased sensitivity to paclitaxel is driven by CDK4 and filamin A.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35065-z

By:

• Mouron, S.;
• Bueno, M. J.;
• Lluch, A.;
• Manso, L.;
• Calvo, I.;
• Cortes, J.;
• Garcia-Saenz, J. A.;
• Gil-Gil, M.;
• Martinez-Janez, N.;
• Apala, J. V.;
• Caleiras, E.;
• Ximénez-Embún, Pilar;
• Muñoz, J.;
• Gonzalez-Cortijo, L.;
• Murillo, R.;
• Sánchez-Bayona, R.;
• Cejalvo, J. M.;
• Gómez-López, G.;
• Fustero-Torre, C.;
• Sabroso-Lasa, S.

Publication type:

Article